Simplify Logo

Full-Time

VP – Franchise Portfolio Management

Confirmed live in the last 24 hours

Azurity Pharmaceuticals

Azurity Pharmaceuticals

201-500 employees

Develops specialized formulations of medicines

Biotechnology
Healthcare

Senior, Expert

Burlington, MA, USA

Hybrid work model: 2 days from home, 3 days in the office.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s degree
  • Pharmaceuticals experience.
  • Entrepreneurial mindset and drive
  • Cross-functional leadership and ability to drive action through others
  • Business acumen
  • Category therapeutic knowledge
  • Familiarity with pharmaceutical drug development, commercial processes and product lifecycles. Understanding of regulatory processes and IP evaluation
  • Strong criteria-based decision-making and execution capabilities.
  • Product selection expertise, creation of TPPs and life-cycle management
  • Curiosity/industry network
  • Financial modeling, forecasting and P&L construction
  • Ability to take a systematic approach, driving forward a large number of projects simultaneously through stage-gate go/no-go decisions
Responsibilities
  • Maintain a comprehensive subject matter expertise for the category through primary and secondary research, ad boards, market scanning, competitive intelligence and customer input.
  • Ideate and select products to construct a funnel of candidates for development, each with a compelling and distinct TPP, subsequently driving progress through development, registration and launch.
  • Continue to drive product enhancements and line-extensions beyond launch and plan effectively for replacement and withdrawal of commercial support at end of life.
  • Own and drive PLM process stage-gates 1-9 at scale and speed (“cradle to grave”), convening and leading A3 Cross-functional teams. Ensure stage-gate criteria are met at every stage. “Push” each function to deliver effectively and to budget at each stage from development, through launch, growth and maturity. Recommend discontinuations as appropriate.
  • Develop and maintain a balanced strategic plan for the category (stage, dose-form, technology etc.), managing replacement of mature assets and growing category revenues over the long-term.
  • Challenge business development to provide assets that supplement the internally developed portfolio.
  • Develop external partnerships to access new technologies and otherwise enhance portfolio development.
Azurity Pharmaceuticals

Azurity Pharmaceuticals

View

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by other pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their commitment to quality and innovation has led to the development of numerous products that significantly benefit patients, positioning Azurity as a key player in the specialized pharmaceutical sector.

Company Stage

Series B

Total Funding

$182.2M

Headquarters

Woburn, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA approval of Myhibbin™ highlights Azurity's capability to bring unique, patient-centric formulations to market, potentially increasing their market share.
  • The acquisition of Slayback Pharma and Arbor Pharmaceuticals expands Azurity's development portfolio, promising a significant number of new medicine launches and enhancing their market position.
  • Azurity's focus on underserved patient segments and innovative dose forms can lead to high patient satisfaction and loyalty, driving long-term growth.

What critics are saying

  • Product recalls, such as the recent Zenzedi recall, can damage Azurity's reputation and lead to financial losses.
  • The specialized nature of their products may limit their market size, making them vulnerable to market fluctuations and competitive pressures.

What makes Azurity Pharmaceuticals unique

  • Azurity Pharmaceuticals focuses on developing innovative dose forms of established medicines, addressing unmet needs in the healthcare market, unlike competitors who may focus solely on new drug development.
  • Their commitment to creating easier-to-administer formulations, such as oral suspensions, sets them apart by enhancing patient compliance and filling gaps in the pharmaceutical market.
  • Azurity's broad therapeutic portfolio and FDA-approved proprietary products ensure they meet stringent regulatory standards, providing a competitive edge in quality and safety.

Help us improve and share your feedback! Did you find this helpful?